… time. Takeda’s dengue vaccine demonstrated strong protection against … FDA was Dengvaxia, which Sanofi Pasteur has stopped making … simplifying administration of the vaccine, especially in public health … funding from Merck and Sanofi and receiving research funding …

… targeted development and succession planning, Sanofi is increasing representation of black … is Sanofi’s partnership with Biovac, which has expanded local vaccine manufacturing … professionals, patients, and advocacy organisations, Sanofi aims to help build a …

… , including Accenture plc (ACN), Sanofi (SNY) and Dell Technologies Inc … approved indications and geographies. Sanofi possesses a leading vaccine portfolio.  Several new … include competitive pressure on influenza vaccines, regular pipeline setbacks and …

… a troubling indifference to vaccine safety data. He mocked … and dismissed glaring weaknesses in vaccine surveillance systems. A System … receiving payments from Merck, Sanofi, GSK, Pfizer, and … very manufacturers of the vaccines he promoted. Plotkin appeared …

… support, technological advancements in vaccine development platforms, and … includes mRNA vaccines, viral vector vaccines, protein subunit vaccines, inactivated whole … Serum Institute of India • Novavax • Sanofi • GlaxoSmithKline • Bharat Biotech • …

… and regional vaccine businesses at CSL Seqirus, Novartis Vaccines and Sanofi Pasteur. … With more than three decades of experience commercialising vaccines … possibility of needle-free vaccine administration that simplifies supply …

… MacGregor led vaccine businesses at CSL Seqirus, Novartis Vaccines and Sanofi Pasteur. His … The possibility of needle-free vaccine administration that simplifies supply chains … facility, supporting HD-MAP vaccine development for later-stage clinical …

… pharmaceutical manufacturing facility owned by Sanofi Pasteur Limited, which employs more … undermines Sanofi’s ability to ensure its ongoing and expanding vaccine research … -million to assist Sanofi in building a new influenza vaccine manufacturing line …

… and regional vaccine businesses at CSL Seqirus, Novartis Vaccines and Sanofi Pasteur. With … more than three decades of experience commercialising vaccines … superior to any other vaccine or vaccine delivery technology. For all …

… demonstrating the feasibility of rapid vaccine development, building global scientific networks … momentum requires continued investment in vaccines, diagnostics, genomic sequencing, surveillance, … the billion-dollar acquisition by Sanofi of a company spun …